| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.2M | -2.4% | +47.6% |
| Cost of Revenue | $2.7M | -1.6% | +43.6% |
| Gross Profit | $570K | -6.1% | +69.3% |
| R&D Expense | $208K | — | — |
| SG&A Expense | $898K | +14.4% | +60.1% |
| Operating Income | -$1.4M | -6.1% | -58.1% |
| Interest Expense | $654K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $0 | — | — |
| Accounts Receivable | $1.5M | -20.1% | +57.8% |
| Inventory | $2.1M | +34.2% | +144.8% |
| Current Assets | $5.5M | +5.0% | +63.4% |
| Total Assets | $14.7M | +11.5% | +53.2% |
| Current Liabilities | $3.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.1M | — | — |
| Capital Expenditures | $574K | — | — |
| Investing Cash Flow | -$574K | — | — |
| Financing Cash Flow | $4.1M | — | — |
| Free Cash Flow | -$5.6M | — | — |
| — |
| Pre-tax Income | -$1.6M | +1.9% | -23.7% |
| Net Income | -$1.6M | +1.9% | -23.7% |
| EPS (Basic) | -$0.14 | +17.6% | +26.3% |
| EPS (Diluted) | -$0.14 | +17.6% | +26.3% |
| -26.4% |
| +26.6% |
| Total Liabilities | $9.5M | -0.7% | +18.7% |
| Stockholders' Equity | $5.1M | +44.3% | +235.3% |